Singular Genomics Systems Inc (OMIC)
0.41
+0.01
(+2.35%)
USD |
NASDAQ |
Apr 26, 11:50
Singular Genomics Systems Enterprise Value: -135.42M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | -135.42M |
| April 24, 2024 | -134.92M |
| April 23, 2024 | -134.40M |
| April 22, 2024 | -135.47M |
| April 19, 2024 | -135.84M |
| April 18, 2024 | -136.29M |
| April 17, 2024 | -135.65M |
| April 16, 2024 | -136.21M |
| April 15, 2024 | -137.17M |
| April 12, 2024 | -133.41M |
| April 11, 2024 | -135.39M |
| April 10, 2024 | -133.72M |
| April 09, 2024 | -130.94M |
| April 08, 2024 | -128.88M |
| April 05, 2024 | -129.37M |
| April 04, 2024 | -129.19M |
| April 03, 2024 | -128.92M |
| April 02, 2024 | -127.77M |
| April 01, 2024 | -127.56M |
| March 28, 2024 | -127.03M |
| March 27, 2024 | -126.83M |
| March 26, 2024 | -127.26M |
| March 25, 2024 | -127.71M |
| March 22, 2024 | -126.97M |
| March 21, 2024 | -128.62M |
| Date | Value |
|---|---|
| March 20, 2024 | -126.34M |
| March 19, 2024 | -127.07M |
| March 18, 2024 | -124.57M |
| March 15, 2024 | -128.08M |
| March 14, 2024 | -127.99M |
| March 13, 2024 | -124.75M |
| March 12, 2024 | -125.84M |
| March 11, 2024 | -125.71M |
| March 08, 2024 | -123.00M |
| March 07, 2024 | -126.97M |
| March 06, 2024 | -126.87M |
| March 05, 2024 | -123.71M |
| March 04, 2024 | -122.15M |
| March 01, 2024 | -120.35M |
| February 29, 2024 | -122.90M |
| February 28, 2024 | -121.72M |
| February 27, 2024 | -121.63M |
| February 26, 2024 | -120.01M |
| February 23, 2024 | -124.44M |
| February 22, 2024 | -126.75M |
| February 21, 2024 | -127.39M |
| February 20, 2024 | -125.99M |
| February 16, 2024 | -124.63M |
| February 15, 2024 | -126.65M |
| February 14, 2024 | -127.76M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-169.50M
Minimum
Sep 20 2023
2.212B
Maximum
Jun 01 2021
130.55M
Average
-84.83M
Median
Enterprise Value Benchmarks
| Bruker Corp | 11.92B |
| Azenta Inc | 1.888B |
| Harvard Bioscience Inc | 186.78M |
| Bionano Genomics Inc | 14.39M |
| Akoya Biosciences Inc | 179.85M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -23.25M |
| Revenue (Quarterly) | 1.081M |
| Total Expenses (Quarterly) | 26.36M |
| EPS Diluted (Quarterly) | -0.31 |
| Gross Profit Margin (Quarterly) | -42.28% |
| Profit Margin (Quarterly) | -2.15K% |
| Earnings Yield | -317.1% |
| Normalized Earnings Yield | -317.07 |